Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Celltrion Inc (068270 KS)
Watchlist
441
Analysis
Health Care
•
South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Celltrion Inc
•
18 Apr 2024 14:51
Locals Driving Corporate Reforms and 10 Korean Companies Recently Announcing Share Cancellations
On 17 April, Celltrion Inc announced that it will buyback shares worth 75 billion won. Including 75 billion won of share repurchase last month,...
Douglas Kim
Follow
487 Views
Share
bullish
•
Celltrion Inc
•
18 Apr 2024 14:07
Celltrion (068270 KS): Solid Performance in Core Business in 2023; Eyes 60% Sales Growth in 2024
Celltrion will cancel 1.1M shares (~10% of holdings) for ~KRW200B. Parallelly, the company announced buyback of 436K shares for ~KRW75B, matching...
Tina Banerjee
Follow
506 Views
Share
bullish
•
Celltrion Inc
•
23 Feb 2024 06:09
FnGuide Top10 Equal Weight Index Rebalance Preview: Celltrion Could Replace Samsung SDI
Celltrion could replace Samsung SDI in the FnGuide Top10 Equal Weight index at the March rebalance. There could be a second change depending on...
Brian Freitas
Follow
450 Views
Share
bullish
•
Celltrion Inc
•
29 Dec 2023 14:00
Celltrion (068270 KS): Record High Revenue and Operating Profit in 3Q23 Solidify Merger Stance
Celltrion Board approved the merger with Celltrion Healthcare. The scheduled date of listing of the new shares is January 12. The merged entity...
Tina Banerjee
Follow
911 Views
Share
bullish
•
Celltrion
•
29 Dec 2023 13:59
Celltrion (068270 KP): Improving Base Business Is Being Overlooked by Mr. Market Amid Merger Noises
Celltrion Board approved the merger with Celltrion Healthcare. The scheduled date of listing of the new shares is January 12. The merged entity...
Tina Banerjee
Follow
775 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.30.3
x